Inside Aesthetics

Episode 150 hosts Dr Stephanie Manson-Brown, a plastic surgeon and an experienced leader in the biotech and pharmaceutical industry.   Dr Manson-Brown is Head of Clinical Development and Vice President of Research and Development at Allergan Aesthetics, an AbbVie company. She and her team are responsible for global clinical trial development strategy for the aesthetics portfolio covering pharmaceuticals and devices.    Stephanie also is the co-founder of the ‘Science of Aging’ platform, being born out of a desire to bring the latest developments from the field of aging science to the aesthetics arena and explore how these discoveries could potentially translate to aesthetic medicine.  We explore: - What exactly R&D means? - How and why Dr Manson-Brown left her surgical career to work in big Pharma? - What Dr Manson-Brown's role is and what her duties are on a day to day basis?  - What actually happens behind the scenes including how are new products and devices are developed? - How other companies are